Brief: NeoDynamics Starts JV For Development Of New Biopsy Instrument
May 22 (Reuters) - NeoDynamics AB NEOD.TE :
* (PUBL) INVESTS IN BIOPSY INSTRUMENT FOR MORE EFFECTIVE
SAMPLING
OF SUSPECTED SKIN CANCER
* NEODYNAMICS HAS OPTION TO INCREASE ITS OWNERSHIP FROM 10
TO 40
PERCENT.
* STARTS A JOINT VENTURE, FOR DEVELOPMENT OF A NEW BIOPSY
INSTRUMENT FOR MORE EFFECTIVE TISSUE SAMPLING OF SUSPECTED SKIN
CANCER
Source text for Eikon: ID:nWkr2fvSY2
Further company coverage: NEOD.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Neodynamics AB (publ)
See all newsBrief: Neodynamics' Stock Is Delisted From Nasdaq First North
Brief: Salénterprise Ownership In NeoDynamics Rises To About 46% After Offer
Brief: NeoDynamics Intends To Apply For Delisting
Brief: Neodynamics Chooses Not To Advise Shareholders On Decision To Accept Offer From Salénterprise
Brief: Salénterprise Makes Cash Offer To Shareholders Neodynamics